RETN and metabolic dysfunction-associated steatotic liver disease: Moreover, MASLD patients exhibited a diminished response to resistin in hepatic myeloid cells and T-lymphocytes; this decline is indicative of an inability to maintain redox homeostasis, a risk factor for the severity of MASLD [233].